#Expert Research: Can CBD effectively impede growth of heterotopic lung cancer?

Jul 24, 2023

3 min

Babak Baban, PhD

Lung cancer is the most chronic form of cancer and the leading cause of cancer mortality in the world, according to studies by the American Lung Association.


Despite recent advances in medical oncology, metastatic lung cancer remains incurable; however, a new discovery by Augusta University researchers has brought new hope to tackling the illness.


That discovery, which stems from a joint preclinic study conducted by scientists from the Dental College of Georgia and the Medical College of Georgia at Augusta University and Medicinal Cannabis of Georgia, LLC, was published in the May 2023 issue of Human Cell.



The study was led by Babak Baban, PhD, associate dean of research, immunologist and professor at DCG and one of the founders of Medicinal Cannabis of Georgia, an Augusta-based biomedical research and developmental company.


The study revealed for the first time that inhalant cannabidiol, commonly referred to as CBD, can effectively impede growth of heterotopic lung cancer.


“The central core of our research has been studying inflammatory diseases and for that we picked two different directions: one is centered around chronic inflammation in our system and the other is neurologic diseases such as dementia. Because of their impressive anti-inflammation effects, CBD, CBC and other cannabinoids have attracted our attention,” Baban said.

“We have had some exciting findings before, and based on those, we built a new model of lung cancer. This is the first time the effect of the CBD has been assessed in inhalant format using an inhaler. This makes it more translatable into humans and more accurate,” he said.

“Obviously, we are just as excited about our discoveries on mechanisms by which CBD worked. They help advance our understanding of the pathophysiology of lung cancer. We have seen some effects on plasticity and cancer stem cells, which appear to be crucial for tumors to regenerate and renew themselves.”



Unlike most anti-angiogenesis drugs, inhalant CBD at the experimental dosage did not show any detectable side effects or toxicity. The findings support the notion that inhalant CBD has enough beneficial effects as a viable complementary modality to be included in combination with current standard treatments for lung cancer.


Additionally, inhalant CBD delivered using a precisely metered dose is non-invasive, and has high translational value, warranting further research through clinical trials for lung cancer and possibly some other malignancies.


“The cannabis plant has over 113 cannabinoids, two of which are very famous: THC and cannabidiol, or CBD. We have conducted extensive research on medicinal cannabis since 2014, but cannabis has been utilized for medicinal purposes for over 1,000 years,” Baban said. “It is not until recently we have started understanding a little better mechanisms how cannabidiols like CBD work.”


Babak Baban is a professor, immunologist and associate dean for research at the Dental College of Georgia at Augusta University where he has served for 13 of his 20 years as a translational and clinical immunologist.


Babak is available to speak to media about this important topic - simply click on his icon now to arrange a time to speak today.

Connect with:
Babak Baban, PhD

Babak Baban, PhD

Associate Dean for Research, Dental College of Georgia

Babak Baban, PhD, is a professor, immunologist and associate dean for research at the Dental College of Georgia at Augusta University.

Cannabidiol (CBD)Lung CancerOral BiologyCancer
Powered by

You might also like...

Check out some other posts from Augusta University

Could Popular Weight-Loss Drugs Be Affecting Your Oral Health? Augusta University Researcher Investigates featured image

2 min

Could Popular Weight-Loss Drugs Be Affecting Your Oral Health? Augusta University Researcher Investigates

GLP-1 medications such as Ozempic, Wegovy and Zepbound are transforming treatment for obesity and diabetes, with some now being used to treat obstructive sleep apnea. But could these increasingly popular medications also affect your teeth and gums? A researcher at Augusta University's Dental College of Georgia is investigating that question, highlighting a potential connection between GLP-1 medications, sleep apnea treatment and oral health. John C. Comisi, DDS, DMD, interim chair and professor in the Department of General Dentistry, recently published a review in Clinical Oral Investigations examining how obstructive sleep apnea and GLP-1 medications may influence the oral microbiome — the complex community of bacteria that helps maintain healthy teeth and gums. A New Question About GLP-1 Medications Obstructive sleep apnea can affect oral health through repeated oxygen disruptions, inflammation, mouth breathing and dry mouth. Treating the condition could improve some of these problems, but GLP-1 medications may introduce additional considerations. “OSA affects much more than sleep,” Comisi said. “The changes that occur throughout the body can also change the environment in the mouth. As we increasingly use medications to treat OSA, we need to understand what those treatments may mean for oral health.” Comisi's review suggests that successful treatment of sleep apnea could improve the oral environment by reducing mouth breathing, acid reflux and other contributing factors. However, reports involving semaglutide have also raised questions about dry mouth and changes in saliva, which plays an important role in protecting against tooth decay and gum disease. “There are potentially competing effects happening at the same time,” Comisi said. “Treating sleep apnea could improve several conditions that contribute to an unhealthy oral environment, while the medication itself could potentially affect salivary function. We simply do not have the prospective human studies yet to know what the overall effect will be.” The review, featured in an Oct. 6 Augusta University Jagwire article, calls for additional research tracking patients using GLP-1 medications, including changes in saliva, oral bacteria, cavities and gum disease. It also highlights the importance of communication between dentists and other health care providers, particularly when patients taking GLP-1 medications require dental procedures involving sedation or general anesthesia. With GLP-1 medications becoming increasingly common, understanding their broader effects on oral health is an emerging area of research with important implications for patients and dental professionals. John C. Comisi, DDS, DMD, is interim chair and professor in the Department of General Dentistry at Augusta University's Dental College of Georgia. His expertise provides a valuable perspective on the intersection of dental health, medication use and emerging approaches to patient care. If you're interested in speaking with Dr. John Comisi about GLP-1 medications, sleep apnea, dry mouth, oral health and the implications of these treatments for dental care, contact  AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

What Marco Rubio's Speech on Ancient Greece Reveals About Leadership, Business and America's Future featured image

2 min

What Marco Rubio's Speech on Ancient Greece Reveals About Leadership, Business and America's Future

What can ancient Greece teach modern America about leadership, economic success and the future of business? That question is at the center of a recent commentary by Rick Franza, PhD, professor at Augusta University's James M. Hull College of Business, published in Augusta Business Daily earlier this month. In his article, "Marco Rubio's Look Back to Move Us Forward: What He Nailed and What He Missed," Franza examines a speech delivered by U.S. Secretary of State Marco Rubio in Athens, Greece, and considers its implications for American businesses, leadership and international relations. Franza explores Rubio's emphasis on ambition, competition, innovation and risk-taking, connecting these themes to the characteristics that have historically contributed to economic development and business success. He also identifies two important considerations he believes deserved greater attention: the role of morality and ethics in leadership and the importance of international trade to economic prosperity. "I am not saying we should be driven by greed and vanity, but rather be willing to continue to strive rather than waiting for others to catch up." Franza's commentary offers a perspective on how lessons from history can inform contemporary discussions about business leadership, economic policy and America's relationships with its international partners. As political and economic debates continue, Franza can help journalists explore the intersection of government policy, business competitiveness, ethical leadership and international commerce. If you're interested in speaking with Dr. Rick Franza about business leadership, economic policy, international trade and the relationship between politics and business, simply click on his profile to arrange an interview today.

AU designated APLU Innovation and Economic Prosperity Institution featured image

4 min

AU designated APLU Innovation and Economic Prosperity Institution

Augusta University has earned national recognition for work that has been taking shape across the university and the region for years: connecting education, research, innovation and workforce development to the needs of the community. After more than three years of collaboration with campus and community partners, AU has been designated an Innovation and Economic Prosperity (IEP) institution by the Association of Public and Land-Grant Universities. This national designation recognizes public research universities that work with public and private sector partners to advance and support economic development in their states and regions. For AU, the IEP designation is both a celebration and a commitment. It recognizes significant work already underway while challenging the university to become even more connected, accessible, measurable and strategic in its economic and community engagement. It also marks an important milestone in its evolution as a public research university, workforce partner, innovation catalyst and community anchor. More than a recognition of programs already underway, the IEP process offered AU an opportunity to examine in depth how many areas of work intersect and how those connections can generate greater impact for students, partners and communities.  “I am grateful to our steering committee and the entire team of campus and community partners whose resolve and determination made this achievement possible,” said Augusta University President Russell T. Keen. “Their efforts truly epitomize our ‘It can be done’ mindset. At its heart, economic prosperity is about people. It means helping students build meaningful careers, preparing the workforce our state needs, turning discoveries into solutions and working alongside our neighbours to build healthier, stronger communities.” AU‘s IEP journey began in early 2023 with an expansive group of CSRA community partners. A steering committee and subcommittees brought together 42 participants representing the university and partners across economic development, K-12 education, local government, community foundations, health systems, the University System of Georgia, the Technical College System of Georgia, the Department of Energy, the Department of Defense, entrepreneurs and other regional stakeholders. This collaborative work continued through significant transitions, including the local impact of Hurricane Helene. The group explored a broad definition of economic prosperity – one that goes beyond traditional measures to include talent development, experiential learning, applied research, entrepreneurship, healthcare access, innovation and mutually beneficial partnerships.  “Augusta University has a unique opportunity, and responsibility, to help drive economic prosperity across the communities we serve,” said Tina Baggott, vice president of Corporate and Community Engagement. “Our work brings together innovation, workforce development and meaningful community partnerships to address the needs of today while helping to prepare our communities for the challenges of tomorrow. The APLU Innovation and Economic Prosperity designation affirms our commitment to working alongside industry, government and community partners to turn ideas into impact, talent into opportunity, and partnerships into lasting economic and community growth.”  Using APLU’s Commission on Economic and Community Engagement assessment tools, peer benchmarking, institutional data, surveys and more than 38 focus groups and individual conversations, the outcome represents the collective work of many in the region, with AU at the helm. “Receiving the IEP designation is a tremendous recognition of what is possible when we bring people together around a shared purpose,” said Lynsey Steinberg, director of Academic Entrepreneurship at AU. “Augusta University has incredible talent, innovative ideas, and strong community partners, and when we connect those strengths, we can make a real difference in supporting regional prosperity. Over the past three years, we have seen what can happen when people collaborate, elevate one another and work toward something bigger than themselves. This designation celebrates that work, but more importantly to keep building relationships, creating connections, and finding new ways to make a meaningful impact together.”  AU’s public mission is equally central to economic prosperity. The university extends healthcare, education, research and community engagement throughout Georgia, including rural and underserved communities. Through its health sciences enterprise, telehealth, clinical education, community partnerships and expansion of programs and campuses, AU is strengthening both access and the talent pipeline required to meet critical workforce needs. “Augusta University has a unique opportunity, and responsibility, to help drive economic prosperity across the communities we serve.” Tina Baggott, vice president of Corporate and Community Engagement. The IEP process reinforced the importance of innovation infrastructure – the systems and connections that help move ideas from discovery to real-world impact. From translational research and commercialization to makerspaces, entrepreneurship programming, interdisciplinary collaboration and the Regional Innovation Advisory Committee – which is focused on advancing AU’s strategic goals of community engagement, student success and research excellence by fostering cross-sector collaborations – AU is building pathways for innovation to move beyond campus into communities, industries and the economy.  “Augusta University’s APLU Innovation and Economic Prosperity designation underscores the university’s important role in strengthening the Augusta region as a place to live, work, invest, and visit,” said Jennifer Bowen, Chief Strategy Officer and Senior Vice President & Film Commissioner at Destination Augusta. “Through innovation, workforce development, research, and community partnerships, AU helps build the talent, opportunities, and economic vitality that make our community more competitive and enhance the region’s appeal as a destination.” The work does not end with this designation. Findings from the IEP self-study have been incorporated into AU’s Growth and Improvement Plan, with priorities focused on stronger coordination, clearer access for partners, improved measurement, increased visibility, workforce alignment and a more intentionally connected regional innovation economy. Economic engagement is also helping shape the university’s next long-term strategic plan, ensuring decisions about academic programs, research, partnerships, infrastructure and investment remain connected to the needs of the communities AU serves. Augusta University will be recognized for this achievement during the APLU Annual Meeting in November in San Antonio, Texas.

View all posts